A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System.

Tang, Linlin; Ding, Chuanhua; Li, Hongying; Zhou, Xueheng; Yin, Guoqiang

Tang, Linlin; Ding, Chuanhua; Li, Hongying; Zhou, Xueheng; Yin, Guoqiang.

Afiliación

Tang L; Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Ding C; Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Li H; Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Zhou X; Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Yin G; Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.

Ann Pharmacother ; 58(4): 375-382, 2024 Apr.

Article en En | MEDLINE | ID: mdl-37522435

Asunto(s)

Anemia Hemolítica; Antineoplásicos; Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos; Masculino; Adulto; Niño; Femenino; Estados Unidos/epidemiología; Humanos; Alemtuzumab; Anemia Hemolítica/inducido químicamente; Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología; Antineoplásicos/efectos adversos; Antibacterianos; United States Food and Drug Administration; Sistemas de Registro de Reacción Adversa a Medicamentos

Palabras clave

FAERS; adverse events; antibiotics; antineoplastic agents; drug-induced immune hemolytic anemia; immunosuppressants

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Anemia Hemolítica / Antineoplásicos Límite: Adult / Child / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Ann Pharmacother Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google